Flow Cytometric Clinical Immunomonitoring Using Peptide–MHC Class II Tetramers: Optimization of Methods and Protocol Development

Overview of attention for article published in Frontiers in immunology, January 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 35,171 followers.

Very interesting paper in @FrontImmunol https://t.co/FFqW0WP0L9

27 Feb 2018

Reply Repost Favourite

RT @FrontImmunol: Flow Cytometric Clinical Immunomonitoring Using Peptide–MHC Class II Tetramers: Optimization of Methods and Protocol Deve…

27 Feb 2018

Reply Repost Favourite

RT @FrontImmunol: Flow Cytometric Clinical Immunomonitoring Using Peptide–MHC Class II Tetramers: Optimization of Methods and Protocol Deve…

27 Feb 2018

Reply Repost Favourite

Flow Cytometric Clinical Immunomonitoring Using Peptide–MHC Class II Tetramers: Optimization of Methods and Protocol Development: Diahann T. S. L. Jansen, Nishta Ramnoruth, Khai L. Loh, Jamie Rossjohn, Hugh H. Reid, Hendrik J. Nel, Ranjeny Thomas https://t

27 Feb 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.